TY - JOUR
T1 - Environmental modifiable risk factors for multiple sclerosis
T2 - Report from the 2016 ECTRIMS focused workshop
AU - For the 2016 ECTRIMS Focused Workshop Group
AU - Amato, Maria Pia
AU - Derfuss, Tobias
AU - Hemmer, Bernard
AU - Liblau, Roland
AU - Montalban, Xavier
AU - Soelberg Sørensen, Per
AU - Miller, David H.
AU - Alfredsson, Lars
AU - Aloisi, Francesca
AU - Ascherio, Alberto
AU - Baldin, Elisa
AU - Bjørnevik, Kjetil
AU - Comabella, Manuel
AU - Correale, Jorge
AU - Cortese, Marianna
AU - Derfuss, Tobias
AU - D’Hooghe, Marie
AU - Ghezzi, Angelo
AU - Gold, Julian
AU - Hellwig, Kerstin
AU - Hemmer, Bernhard
AU - Koch-Henricksen, Nils
AU - Langer Gould, Annette
AU - Liblau, Roland
AU - Linker, Ralf
AU - Lolli, Francesco
AU - Lucas, Robyn
AU - Lünemann, Jan
AU - Magyari, Melinda
AU - Massacesi, Luca
AU - Miller, Ariel
AU - Miller, David H.
AU - Monteyne, Philippe
AU - Mowry, Ellen
AU - Münz, Christian
AU - Nielsen, Nete M.
AU - Olsson, Tomas
AU - Oreja-Guevara, Celia
AU - Otero, Susana
AU - Pugliatti, Maura
AU - Reingold, Stephen
AU - Riise, Trond
AU - Robertson, Neil
AU - Salvetti, Marco
AU - Sidhom, Youssef
AU - Smolders, Joost
AU - Soelberg Sørensen, Per
AU - Sollid, Ludvig
AU - Steiner, Israel
AU - Stenager, Egon
N1 - Publisher Copyright:
© 2017, © The Author(s), 2017.
PY - 2018/4/1
Y1 - 2018/4/1
N2 - Multiple sclerosis (MS) is an inflammatory and neurodegenerative demyelinating disease of the central nervous system (CNS), most likely autoimmune in origin, usually beginning in early adulthood. The aetiology of the disease is not well understood; it is viewed currently as a multifactorial disease which results from complex interactions between genetic predisposition and environmental factors, of which a few are potentially modifiable. Improving our understanding of these factors can lead to new and more effective approaches to patient counselling and, possibly, prevention and management of the disease. The 2016 focused workshop of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) addressed the topic of environmental, modifiable risk factors for MS, gathering experts from around the world, to collate experimental and clinical research into environmental factors that have been associated with the disease onset and, in a few cases, disease activity and progression. A number of factors, including infections, vitamin D deficiency, diet and lifestyle factors, stress and comorbidities, were discussed. The meeting provided a forum to analyse available evidence, to identify inconsistencies and gaps in current knowledge and to suggest avenues for future research.
AB - Multiple sclerosis (MS) is an inflammatory and neurodegenerative demyelinating disease of the central nervous system (CNS), most likely autoimmune in origin, usually beginning in early adulthood. The aetiology of the disease is not well understood; it is viewed currently as a multifactorial disease which results from complex interactions between genetic predisposition and environmental factors, of which a few are potentially modifiable. Improving our understanding of these factors can lead to new and more effective approaches to patient counselling and, possibly, prevention and management of the disease. The 2016 focused workshop of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) addressed the topic of environmental, modifiable risk factors for MS, gathering experts from around the world, to collate experimental and clinical research into environmental factors that have been associated with the disease onset and, in a few cases, disease activity and progression. A number of factors, including infections, vitamin D deficiency, diet and lifestyle factors, stress and comorbidities, were discussed. The meeting provided a forum to analyse available evidence, to identify inconsistencies and gaps in current knowledge and to suggest avenues for future research.
KW - Multiple sclerosis
KW - comorbidities
KW - environmental risk factors
KW - infections
KW - lifestyle
KW - vitamin D
UR - http://www.scopus.com/inward/record.url?scp=85029620990&partnerID=8YFLogxK
U2 - 10.1177/1352458516686847
DO - 10.1177/1352458516686847
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
C2 - 28671487
AN - SCOPUS:85029620990
SN - 1352-4585
VL - 24
SP - 590
EP - 603
JO - Multiple Sclerosis Journal
JF - Multiple Sclerosis Journal
IS - 5
ER -